Wird geladen...

Iron therapy for renal anemia: how much needed, how much harmful?

Iron deficiency is the most common cause of hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) in end-stage renal disease (ESRD) patients. Iron deficiency can easily be corrected by intravenous iron administration, which is more effective than oral iron supplementation, at least in adult...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Hörl, Walter H.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Berlin Heidelberg 2007
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1805051/
https://ncbi.nlm.nih.gov/pubmed/17206511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-006-0405-y
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!